Clonal Hematopoiesis of Indeterminate Potential and Bone Mineral Density in Cohorts from Trans-Omics for Precision Medicine

Clicks: 10
ID: 337531
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #142 of 143 articles by views in journal of bone and mineral research : the official journal of the american society for bone and mineral research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 143 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A somatic mutation causing clonal expansion in hematopoietic stem cells (HSC), but not resulting in hematologic malignancy, is termed clonal hematopoiesis of indeterminate potential (CHIP). CHIP is associated with non-hematologic disorders, including accelerated atherosclerosis, heart failure, ischemic stroke, gout, liver disease, and kidney disease. Because osteoclasts are derived from the macrophage-monocyte lineage of HSCs, changes in the bone marrow niche due to CHIP may drive changes in BMD. To investigate whether CHIP may be related to BMD, we used CHIP mutation calls from the Trans-omics for Precision Medicine (TOPMed) whole genome sequencing data and DXA derived BMD from multiple cohorts. Data from the the Amish cohort, Cardiovascular Health Study, the Framingham Heart Study, San Antonio Family Study, and the Women's Health Initiative were combined for analysis. Multiple linear regression was used to determine the association between CHIP mutation status and BMD, adjusting for cohort, age, age,2 sex, and, for family-based cohorts, empiric kinship estimated from genotype data. CHIP mutation status was analyzed both as a binary variable (any CHIP mutation) and as an ordinal variable (no CHIP mutation, 1 CHIP mutation in any gene, two or more CHIP mutations in a single gene, two or more CHIP mutations in different genes). A total of 3368 samples had both CHIP and BMD data, and 10.9% of samples contained any CHIP mutation. The presence of any CHIP mutations was not associated with either femoral neck or lumbar spine BMD; however, the presence of two or more CHIP mutations in different genes was positively associated with LSBMD (beta = 0.36, p = .015). We found no overall association between the presence of CHIP mutations and BMD in a large, diverse sample of genomes. Our findings of greater BMD in persons harboring multiple CHIP mutations confirm mouse models demonstrating that Dnmt3a and Tet2 mutations independently cause increased BMD.
Reference Key
openalex_W7224093599 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Douglas P. Kiel, Wingel Xue, Hanfei Xu, Alexander G. Bick, Carolyn J. Crandall, Yi‐Hsiang Hsu, David Karasik, Braxton D. Mitchell, May E. Montasser, Joshua S. Weinstock, Kerri L. Wiggins, C.T. Liu, Rebecca D. Jackson
Are you one of these authors? Claim your profile
Journal journal of bone and mineral research : the official journal of the american society for bone and mineral research
Year 2026
DOI
10.1093/jbmr/zjag148
URL
https://doi.org/10.1093/jbmr/zjag148
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.